Physician profile
Daniel Fama
NPI 1629695051
$1,137.73
in general payments reported to CMS, 2019-2025
7 companies · $216 in 2025
The $216 reported for 2025 was more than what 77% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.28 · 2022: $16.68 · 2023: $285 · 2024: $608 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612 · Gift: $414 · Entertainment: $42.34 · Education: $40.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.71 |
| Gift | $413.95 |
| Entertainment | $42.34 |
| Education | $40.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Premier Dental Products Company | $413.95 | 2024 | Big Easy Ultralite 204s |
| Align Technology, INC. | $295.63 | 2023-2025 | Invisalign, Invisalign System - Moderate |
| Straumann USA LLC | $168.98 | 2024-2025 | |
| Dental Health Products, INC. | $107.08 | 2023 | |
| Dentsply Sirona INC | $63.02 | 2021-2023 | Cavitron |
| Solventum Corporation | $48.30 | 2025 | 3m Filtek, 3m Scotchbond |
| Gc America INC. | $40.77 | 2023 | Gc Fuji |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Fama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.